Email Updates

You are here

AVAC's Blog: P-Values

  • In this unprecedented time, AVAC has been urgently gathering evidence-based information on COVID-19 and the research underway to treat or prevent it. We are sharing these resources with you today—scroll down to dig in immediately.

    April 9, 2020
    AVAC
  • Advocacy organizations around the world have initiated a call for ethical research for COVID-19 solutions asking for treatment and prevention options around the globe along with ethical and inclusive R&D to meet this critical need.

    April 8, 2020
    AVAC
  • What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster.

    April 6, 2020
    Stacey Hannah
  • There’s much we do and don’t know about COVID-19 and the virus that causes it. The global response to COVID-19, which is evolving rapidly, can and must benefit from lessons learned in the fight against HIV. AVAC is committed to data-driven, evidence-based advocacy, and we hope these resources help us all stay up-to-date on the facts, share experiences and make sure interventions for COVID-19 and HIV reach those who need them the most.

    April 2, 2020
    AVAC
  • It is with an incredibly heavy heart that we mourn the passing of Gita Ramjee on Tuesday, March 30 of COVID-19 related complications. She was a great friend to AVAC over the years – and she was an essential partner in helping to navigate the field through more disappointing results than any of us wanted. But those results never deterred her tireless determination to keep pushing for the next trial. Gita will be sorely missed by all of us who had the privilege to work with her. May we all build on her legacy and make her calling, her dream a reality.

    April 1, 2020
    General
    Mitchell Warren
  • Many of us are focused on the global—and in most cases very personal—response to the COVID-19 pandemic, but the work in the fight against HIV continues apace. In this update, AVAC shares the essential work of civil society groups and activists who are influencing PEPFAR programming for the coming year. Their continuing advocacy led to important wins, gained over the three weeks spent at the Regional Planning Meetings (RPMs) in Johannesburg.

    April 1, 2020
    AVAC
  • In the second installment of AVAC’s webinar series on COVID-19 and its relationship to HIV, Dr. Mark Feinberg, CEO of IAVI, shared experiences and lessons from Ebola and HIV vaccine development that might be applied to COVID-19 vaccine development. Dr. Feinberg was joined by Dr. Helen Rees of Wits RHI to discuss the history and role of the Coalition for Epidemic Preparedness Innovations (CEPI), which supports vaccine development against emerging infectious diseases, including COVID-19.

    March 26, 2020
    AVAC
  • AVAC is committed to data-driven, evidence-based advocacy, and we hope these resources help us all stay up-to-date on the facts, share experiences and make sure interventions for COVID-19 and HIV reach those who need them the most.

    March 23, 2020
    AVAC
  • On Monday, March 23 we were joined by Dr. Carl Dieffenbach, Director of the Division of AIDS (DAIDS) at the NIH, Lillian Mworeko of ICW-EA and Yvette Raphael of APHA, to answer questions about what we do and don’t know about COVID-19 and HIV, how to track research developments on the HIV front, what this new pandemic might mean for ongoing HIV research, and how the HIV community can contribute to the fight against COVID-19.

    March 19, 2020
    General
    AVAC
  • In late February, we reported back from week one of the Regional Planning Meetings (RPM) in Johannesburg where representatives from programs under the US Government’s President’s Emergency Plan for AIDS Relief (PEPFAR) meet to make plans, set targets and define approaches, ultimately captured in Country Operational Plans (COPs) for more than 50 countries around the world.

    March 12, 2020
    AVAC

Pages